It may be appropriate to screen for melanoma and pancreatic cancer in addition to prostate and breast cancer among men carrying BRCA mutations, according to a research letter published in JAMA Oncology.
“Men with germline mutations in BRCA1 and BRCA2 genes have a higher risk [for] developing malignant abnormalities of the prostate, pancreas, breast, colon and melanoma,” David Margel, MD, PhD, associate professor in the department of urology at Rabin Medical Center in Israel, and colleagues wrote. Read more . . .